Evernorth and Transcarent Collaborate to Deliver Unmatched Cancer Care, Navigation, and Support Services Starting January 1, 2025 Transcarent, known as the One Place for Health and Care, has been selected…
Over 50 Research Studies by IVI RMA North America Set to Advance Infertility Care at ASRM 2024 IVI RMA North America, which encompasses Reproductive Medicine Associates and Boston IVF, will…
Survey Reveals 78% of Patients Experience Anxiety During Blood Draws; 74% Want Painless Home Collection Solutions Tasso, Inc., a leading provider of patient-centric blood collection solutions, surveyed over 600 adults…
Charles River Laboratories International, Inc. (NYSE: CRL) has launched the Retrogenix® Non-Human Protein Library, a first-in-class in vitro tool designed to help biopharmaceutical clients assess off-target binding within a non-human…
1910 Genetics Launches CANDID-CNS™, an AI Model for Blood-Brain Barrier Permeability Prediction 1910 Genetics, a biotechnology company specializing in small and large molecule drug discovery, has announced the launch of…
Alterome Therapeutics, Inc. Recognized at Goldman Sachs Builders and Innovators Summit Alterome Therapeutics, Inc., a biopharmaceutical company specializing in next-generation small molecule targeted therapies for cancer, announced that Eric Murphy,…
iProov Reports 63% Transaction Growth Amid Rising Demand for Biometric Solutions iProov, a leader in biometric identity solutions, announced a remarkable 63% increase in transaction volume on its platform from…
Minze Health Secures $5.3 Million in Funding to Advance Digital Health Solutions for Urology Minze Health, a leader in digital health solutions tailored for urology, has successfully raised $5.3 million…
Modivcare Partners with Tenovi to Enhance Respiratory Care Using Adherium’s Hailie® Smart Inhalers Modivcare Inc., a prominent technology-enabled healthcare services company, has announced a partnership with Tenovi, a pioneer in…
Sage Therapeutics, Inc. (Nasdaq: SAGE) has unveiled a strategic reorganization initiative aimed at prioritizing the commercialization of ZURZUVAE® for postpartum depression while sharpening its focus on pipeline development, including the…
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a company focused on developing innovative therapies for seizure disorders, has shared new data from its Phase 3 RAISE trial on intravenous (IV) ganaxolone for…
Artesunate AMIVAS, the first fully licensed treatment for severe malaria in Europe, is now available for purchase across Europe and the U.K. through Nordic Prime in Denmark. Approved by the…